Four Thought Financial, LLC Global Blood Therapeutics, Inc. Transaction History

Four Thought Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$22.3 - $37.39 $4,816 - $8,076	216 Added 20.47%	1,271 $41,000
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $1,324 - $1,941	52 Added 5.18%	1,055 $26,000
Q2 2021 Nov 12, 2021	SELL	$32.46 - $43.42 $177,199 - $237,029	-5,459 Reduced 84.48%	1,003 $35,000
Q1 2021 Nov 12, 2021	BUY	$38.94 - $50.85 $20,521 - $26,797	527 Added 8.88%	6,462 $263,000
Q4 2020 Nov 12, 2021	BUY	$37.65 - $63.77 $223,452 - $378,474	5,935 New	5,935 $257,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial, LLC with notifications on news.